USD
  • Dollar (USD)
  • Euro (EUR)

Vectormune HVT-AIV Vaccine

Home/Veterinary Medicines/EU Authorised (267)/Vectormune HVT-AIV Vaccine

Vectormune HVT-AIV Vaccine

In Stock

Vectormune HVT-AIV is a vaccine used for the active immunization of chickens against pathogenic avian influenza (HPAI) virus of the H5 subtype and Marek's disease. Helps reduce mortality, clinical signs, and virus excretion in vaccinated chickens infected with HPAI of the H5 subtype.

Vectormune HVT-AIV is a vaccine used for the active immunization of chickens against pathogenic avian influenza (HPAI) virus of the H5 subtype and Marek’s disease. Helps reduce mortality, clinical signs, and virus excretion in vaccinated chickens infected with HPAI of the H5 subtype.
  • Administered as a live vector frozen vaccine, typically by subcutaneous injection to one-day-old chicks.
  • Protection against HPAI starts after 2 weeks of age.
  • Duration of immunity for HPAI is at least 19 weeks.
  • Allows for differentiating infected from vaccinated animals (DIVA) because it only elicits antibodies against the H5 protein, enabling the detection of field infection and supporting eradication effort

Reviews

There are no reviews yet.

Be the first to review “Vectormune HVT-AIV Vaccine”

Your email address will not be published. Required fields are marked *

No shipping rates are available for this product.
Your Cart
0

Your cart is empty.

Return to Shop
Added to cart